Last update 25 Aug 2025

Wharton jelly mesenchymal stem cells (University of Jordan)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms
Allogeneic Wharton Jelly Mesenchymal Stromal Cell (University of Jordan)
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Nervous System Diseases
Active Indication
Autistic Disorder
Inactive Indication
Colitis, UlcerativeDiabetic NephropathiesErectile dysfunction due to diabetes mellitus+ [1]
Originator Organization
The University of JordanThe University of Jordan
Active Organization
The University of JordanThe University of Jordan
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with Wharton jelly mesenchymal stem cells (University of Jordan)
NCT06293950
/ RecruitingPhase 1IIT
Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism
NCT03288571
/ Unknown statusPhase 1/2IIT
The Safety of Intra-parenchymal Wharton Jelly Mesenchymal Stem Cell Injection in the Treatment of Diabetic Nephropathy
NCT03299413
/ Unknown statusPhase 1/2IIT
Ulcerative Colitis Stem Cell Therapy
100 Clinical Results associated with Wharton jelly mesenchymal stem cells (University of Jordan)
Login to view more data
100 Translational Medicine associated with Wharton jelly mesenchymal stem cells (University of Jordan)
Login to view more data
100 Patents (Medical) associated with Wharton jelly mesenchymal stem cells (University of Jordan)
Login to view more data
100 Deals associated with Wharton jelly mesenchymal stem cells (University of Jordan)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetic NephropathiesPhase 2-
The University of JordanThe University of Jordan
01 Nov 2019
Colitis, UlcerativePhase 2
Jordan
The University of JordanThe University of Jordan
05 Jun 2017
Erectile dysfunction due to diabetes mellitusPhase 2
Jordan
The University of JordanThe University of Jordan
27 Jan 2017
Autistic DisorderPhase 1
Jordan
The University of JordanThe University of Jordan
09 Mar 2022
Osteoarthritis, KneePhase 1
Jordan
The University of JordanThe University of Jordan
27 Jan 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free